{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:28:27Z","timestamp":1787124507086,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Health Science and Technology Plan of Zhejiang Province","award":["2025HY1535"],"award-info":[{"award-number":["2025HY1535"]}]},{"name":"the Health Science and Technology Plan of Zhejiang Province","award":["2024KY1848"],"award-info":[{"award-number":["2024KY1848"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00920-2","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:13:32Z","timestamp":1787123612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CHFR drives gastric cancer stemness and hepatic metastasis by suppressing ITCH-mediated ubiquitination and degradation of OCT4"],"prefix":"10.1186","volume":"21","author":[{"given":"Mugen","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jundi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7533-9963","authenticated-orcid":false,"given":"Bin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"920_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"920_CR2","first-page":"635","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer Lancet. 2020;396:635\u201348.","journal-title":"Gastric cancer Lancet"},{"key":"920_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20:1493\u2013505.","journal-title":"Lancet Oncol"},{"key":"920_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejca.2022.08.015","volume":"175","author":"J Hemminki","year":"2022","unstructured":"Hemminki J, F\u00f6rsti A, Hemminki A, et al. Survival trends in solid cancers in the Nordic countries through 50 years. Eur J Cancer. 2022;175:77\u201385.","journal-title":"Eur J Cancer"},{"key":"920_CR5","doi-asserted-by":"publisher","first-page":"52307","DOI":"10.18632\/oncotarget.10740","volume":"7","author":"M Riihim\u00e4ki","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist K, et al. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7:52307\u201316.","journal-title":"Oncotarget"},{"key":"920_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jso.20739","volume":"95","author":"Y Sakamoto","year":"2007","unstructured":"Sakamoto Y, Sano T, Shimada K, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol. 2007;95:534\u20139.","journal-title":"J Surg Oncol"},{"key":"920_CR7","doi-asserted-by":"publisher","first-page":"e923867","DOI":"10.12659\/MSM.923867","volume":"26","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lin Y, Duan J, et al. A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer. Med Sci Monit. 2020;26:e923867.","journal-title":"Med Sci Monit"},{"key":"920_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.critrevonc.2009.01.004","volume":"71","author":"V Catalano","year":"2009","unstructured":"Catalano V, Labianca R, Beretta GD, et al. Gastric cancer. Crit Rev Oncol Hematol. 2009;71:127\u201364.","journal-title":"Crit Rev Oncol Hematol"},{"key":"920_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10120-022-01357-y","volume":"26","author":"J Giraud","year":"2023","unstructured":"Giraud J, Seeneevassen L, Rousseau B, et al. CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma. Gastric Cancer. 2023;26:234\u201349.","journal-title":"Gastric Cancer"},{"key":"920_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41420-024-01839-1","volume":"10","author":"L Seeneevassen","year":"2024","unstructured":"Seeneevassen L, Zaafour A, Sifr\u00e9 E, et al. Targeting metastasis-initiating cancer stem cells in gastric cancer with leukaemia inhibitory factor. Cell Death Discov. 2024;10:120.","journal-title":"Cell Death Discov"},{"key":"920_CR11","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/jcp.25759","volume":"232","author":"MR Abbaszadegan","year":"2017","unstructured":"Abbaszadegan MR, Bagheri V, Razavi MS, et al. Isolation, identification, and characterization of cancer stem cells: A review. J Cell Physiol. 2017;232:2008\u201318.","journal-title":"J Cell Physiol"},{"key":"920_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J, et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther. 2024;9:170.","journal-title":"Signal Transduct Target Ther"},{"key":"920_CR13","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.7150\/thno.41648","volume":"10","author":"T Huang","year":"2020","unstructured":"Huang T, Song X, Xu D, et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10:8721\u201343.","journal-title":"Theranostics"},{"key":"920_CR14","doi-asserted-by":"crossref","unstructured":"Rigaud VOC, Hoy R, Mohsin S, et al. Stem cell metabolism: powering cell-based therapeutics. Cells. 2020;9.","DOI":"10.3390\/cells9112490"},{"key":"920_CR15","doi-asserted-by":"publisher","first-page":"627745","DOI":"10.3389\/fendo.2021.627745","volume":"12","author":"M Robles-Flores","year":"2021","unstructured":"Robles-Flores M, Moreno-Londo\u00f1o AP, Casta\u00f1eda-Patl\u00e1n MC. Signaling Pathways Involved in Nutrient Sensing Control in Cancer Stem Cells: An Overview. Front Endocrinol (Lausanne). 2021;12:627745.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"920_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00280-022-04398-3","volume":"89","author":"C Du","year":"2022","unstructured":"Du C, Guan X, Liu Y, et al. Disulfiram\/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc. Cancer Chemother Pharmacol. 2022;89:451\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"920_CR17","doi-asserted-by":"publisher","first-page":"101932","DOI":"10.1016\/j.mcp.2023.101932","volume":"72","author":"L Zhan","year":"2023","unstructured":"Zhan L, Wu W, Yang Q, et al. Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric cancer cells by activating PKMYT1. Mol Cell Probes. 2023;72:101932.","journal-title":"Mol Cell Probes"},{"key":"920_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bbrc.2010.04.052","volume":"395","author":"JM Kim","year":"2010","unstructured":"Kim JM, Cho EN, Kwon YE, et al. CHFR functions as a ubiquitin ligase for HLTF to regulate its stability and functions. Biochem Biophys Res Commun. 2010;395:515\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"920_CR19","doi-asserted-by":"publisher","first-page":"10083","DOI":"10.18632\/oncotarget.23394","volume":"9","author":"Y Ding","year":"2018","unstructured":"Ding Y, Lian HF, Du Y. Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis. Oncotarget. 2018;9:10083\u201390.","journal-title":"Oncotarget"},{"key":"920_CR20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.7150\/jca.27224","volume":"10","author":"D Dai","year":"2019","unstructured":"Dai D, Zhou B, Xu W, et al. CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process. J Cancer. 2019;10:949\u201356.","journal-title":"J Cancer"},{"key":"920_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12876-023-02724-4","volume":"23","author":"F He","year":"2023","unstructured":"He F, Ye B, Wu X, et al. CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis. BMC Gastroenterol. 2023;23:114.","journal-title":"BMC Gastroenterol"},{"key":"920_CR22","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2147\/OTT.S191016","volume":"12","author":"S Yang","year":"2019","unstructured":"Yang S, He F, Dai M, et al. CHFR promotes the migration of human gastric cancer cells by inducing epithelial-to-mesenchymal transition in a HDAC1-dependent manner. Onco Targets Ther. 2019;12:1075\u201384.","journal-title":"Onco Targets Ther"},{"key":"920_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1368-7646(02)00121-8","volume":"5","author":"TR Pray","year":"2002","unstructured":"Pray TR, Parlati F, Huang J, et al. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat. 2002;5:249\u201358.","journal-title":"Drug Resist Updat"},{"key":"920_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cbpa.2019.11.012","volume":"56","author":"A Hanzl","year":"2020","unstructured":"Hanzl A, Winter GE. Targeted protein degradation: current and future challenges. Curr Opin Chem Biol. 2020;56:35\u201341.","journal-title":"Curr Opin Chem Biol"},{"key":"920_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2017.04.002","volume":"398","author":"Y Gen","year":"2017","unstructured":"Gen Y, Yasui K, Kitaichi T, et al. ASPP2 suppresses invasion and TGF-beta1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer. Cancer Lett. 2017;398:52\u201361.","journal-title":"Cancer Lett"},{"key":"920_CR26","doi-asserted-by":"publisher","first-page":"17443","DOI":"10.1038\/s41598-020-74452-8","volume":"10","author":"Y Peng","year":"2020","unstructured":"Peng Y, Wang HH. Cir-ITCH inhibits gastric cancer migration, invasion and proliferation by regulating the Wnt\/beta-catenin pathway. Sci Rep. 2020;10:17443.","journal-title":"Sci Rep"},{"key":"920_CR27","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1161\/HYPERTENSIONAHA.120.15487","volume":"76","author":"J Goto","year":"2020","unstructured":"Goto J, Otaki Y, Watanabe T, et al. HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt\/\u03b2-Catenin Signaling Pathway. Hypertension. 2020;76:1868\u201378.","journal-title":"Hypertension"},{"key":"920_CR28","doi-asserted-by":"publisher","first-page":"11764","DOI":"10.1074\/jbc.RA120.014298","volume":"295","author":"X Lin","year":"2020","unstructured":"Lin X, Zhang H, Boyce BF, et al. Ubiquitination of interleukin-1\u03b1 is associated with increased pro-inflammatory polarization of murine macrophages deficient in the E3 ligase ITCH. J Biol Chem. 2020;295:11764\u201375.","journal-title":"J Biol Chem"},{"key":"920_CR29","doi-asserted-by":"publisher","first-page":"668743","DOI":"10.3389\/fonc.2021.668743","volume":"11","author":"C Wang","year":"2021","unstructured":"Wang C, Li H, Wu L, et al. Coiled-Coil Domain-Containing 68 Downregulation Promotes Colorectal Cancer Cell Growth by Inhibiting ITCH-Mediated CDK4 Degradation. Front Oncol. 2021;11:668743.","journal-title":"Front Oncol"},{"key":"920_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41418-020-00613-x","volume":"28","author":"EK Do","year":"2021","unstructured":"Do EK, Moon HJ, Kang KT, et al. Kap1 regulates the self-renewal of embryonic stem cells and cellular reprogramming by modulating Oct4 protein stability. Cell Death Differ. 2021;28:685\u201399.","journal-title":"Cell Death Differ"},{"key":"920_CR31","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/jcp.24297","volume":"228","author":"B Liao","year":"2013","unstructured":"Liao B, Zhong X, Xu H, et al. Itch, an E3 ligase of Oct4, is required for embryonic stem cell self-renewal and pluripotency induction. J Cell Physiol. 2013;228:1443\u201351.","journal-title":"J Cell Physiol"},{"key":"920_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.stemcr.2018.09.001","volume":"11","author":"S Li","year":"2018","unstructured":"Li S, Xiao F, Zhang J, et al. Disruption of OCT4 ubiquitination increases OCT4 protein stability and ASH2L-B-mediated H3K4 methylation promoting pluripotency acquisition. Stem Cell Rep. 2018;11:973\u201387.","journal-title":"Stem Cell Rep"},{"key":"920_CR33","doi-asserted-by":"crossref","unstructured":"Rhie BH, Antao AM, Karapurkar JK, et al. Ubiquitin-specific protease 3 deubiquitinates and stabilizes OCT4 protein in human embryonic stem cells. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22115584"},{"key":"920_CR34","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.jbior.2020.100777","volume":"79","author":"EJ Sohn","year":"2021","unstructured":"Sohn EJ, Moon HJ, Lim JK, et al. Regulation of the protein stability and transcriptional activity of OCT4 in stem cells. Adv Biol Regul. 2021;79:100777.","journal-title":"Adv Biol Regul"},{"key":"920_CR35","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/bjc.2016.152","volume":"114","author":"P Sancho","year":"2016","unstructured":"Sancho P, Barneda D, Heeschen C. Hallmarks of cancer stem cell metabolism. Br J Cancer. 2016;114:1305\u201312.","journal-title":"Br J Cancer"},{"key":"920_CR36","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.1007\/s00018-021-03975-8","volume":"78","author":"EI Bakhmet","year":"2021","unstructured":"Bakhmet EI, Tomilin AN. Key features of the POU transcription factor Oct4 from an evolutionary perspective. Cell Mol Life Sci. 2021;78:7339\u201353.","journal-title":"Cell Mol Life Sci"},{"key":"920_CR37","doi-asserted-by":"publisher","first-page":"216875","DOI":"10.1016\/j.canlet.2024.216875","volume":"593","author":"X Jiang","year":"2024","unstructured":"Jiang X, You H, Niu Y, et al. E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability. Cancer Lett. 2024;593:216875.","journal-title":"Cancer Lett"},{"key":"920_CR38","doi-asserted-by":"publisher","first-page":"17796","DOI":"10.3748\/wjg.v20.i47.17796","volume":"20","author":"S Kagawa","year":"2014","unstructured":"Kagawa S, Shigeyasu K, Ishida M, et al. Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients. World J Gastroenterol. 2014;20:17796\u2013803.","journal-title":"World J Gastroenterol"},{"key":"920_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10:627\u201342.","journal-title":"Trends Cancer"},{"key":"920_CR40","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ L\u00f3pez","year":"2023","unstructured":"L\u00f3pez MJ, Carbajal J, Alfaro AL, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181:103841.","journal-title":"Crit Rev Oncol Hematol"},{"key":"920_CR41","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cncr.30538","volume":"123","author":"T Bekaii-Saab","year":"2017","unstructured":"Bekaii-Saab T, El-Rayes B. Identifying and targeting cancer stem cells in the treatment of gastric cancer. Cancer. 2017;123:1303\u201312.","journal-title":"Cancer"},{"key":"920_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12935-021-01840-z","volume":"21","author":"M Razmi","year":"2021","unstructured":"Razmi M, Ghods R, Vafaei S, et al. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis. Cancer Cell Int. 2021;21:139.","journal-title":"Cancer Cell Int"},{"key":"920_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li D, Wang Y, Dong C, et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42:83\u201398.","journal-title":"Oncogene"},{"key":"920_CR44","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00018-011-0892-2","volume":"69","author":"S Sanbhnani","year":"2012","unstructured":"Sanbhnani S, Yeong FM. CHFR: a key checkpoint component implicated in a wide range of cancers. Cell Mol Life Sci. 2012;69:1669\u201387.","journal-title":"Cell Mol Life Sci"},{"key":"920_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10555-013-9462-4","volume":"33","author":"S Derks","year":"2014","unstructured":"Derks S, Cleven AH, Melotte V, et al. Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine. Cancer Metastasis Rev. 2014;33:161\u201371.","journal-title":"Cancer Metastasis Rev"},{"key":"920_CR46","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"920_CR47","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijbs.69411","volume":"18","author":"S Han","year":"2022","unstructured":"Han S, Wang R, Zhang Y, et al. The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci. 2022;18:2292\u2013303.","journal-title":"Int J Biol Sci"},{"key":"920_CR48","doi-asserted-by":"crossref","unstructured":"Wu W, Yang J, Yu T, et al. The role and mechanism of TRIM proteins in gastric cancer. Cells. 2024;13.","DOI":"10.3390\/cells13242107"},{"key":"920_CR49","doi-asserted-by":"publisher","first-page":"e2303807","DOI":"10.1002\/advs.202303807","volume":"10","author":"J Ren","year":"2023","unstructured":"Ren J, Yu P, Liu S, et al. Deubiquitylating Enzymes in Cancer and Immunity. Adv Sci (Weinh). 2023;10:e2303807.","journal-title":"Adv Sci (Weinh)"},{"key":"920_CR50","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23:842\u201362.","journal-title":"Nat Rev Cancer"},{"key":"920_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/carcin\/bgaa098","volume":"42","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xu J, Fu H, et al. UBE3C promotes proliferation and inhibits apoptosis by activating the \u03b2-catenin signaling via degradation of AXIN1 in gastric cancer. Carcinogenesis. 2021;42:285\u201393.","journal-title":"Carcinogenesis"},{"key":"920_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00018-022-04320-3","volume":"79","author":"T Zhou","year":"2022","unstructured":"Zhou T, Chen T, Lai B, et al. FBXW2 inhibits prostate cancer proliferation and metastasis via promoting EGFR ubiquitylation and degradation. Cell Mol Life Sci. 2022;79:268.","journal-title":"Cell Mol Life Sci"},{"key":"920_CR53","doi-asserted-by":"publisher","first-page":"216923","DOI":"10.1016\/j.canlet.2024.216923","volume":"592","author":"Z Wu","year":"2024","unstructured":"Wu Z, Zhang J, Jia Z, et al. TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer. Cancer Lett. 2024;592:216923.","journal-title":"Cancer Lett"},{"key":"920_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13238-018-0586-8","volume":"10","author":"D Aki","year":"2019","unstructured":"Aki D, Li Q, Li H, et al. Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch. Protein Cell. 2019;10:395\u2013404.","journal-title":"Protein Cell"},{"key":"920_CR55","doi-asserted-by":"publisher","first-page":"8828299","DOI":"10.1155\/2021\/8828299","volume":"2021","author":"XD Sun","year":"2021","unstructured":"Sun XD, Huan C, Sun DW, et al. Prognostic and Clinicopathological Significance of Circular RNA circ-ITCH Expression in Cancer Patients: A Meta-analysis. Biomed Res Int. 2021;2021:8828299.","journal-title":"Biomed Res Int"},{"key":"920_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcancer.2020.03.003","volume":"67","author":"Q Yin","year":"2020","unstructured":"Yin Q, Wyatt CJ, Han T, et al. ITCH as a potential therapeutic target in human cancers. Semin Cancer Biol. 2020;67:117\u201330.","journal-title":"Semin Cancer Biol"},{"key":"920_CR57","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1515\/hmbci-2011-0130","volume":"9","author":"V Govindaraj","year":"2012","unstructured":"Govindaraj V, Yaduvanshi NS, Krishnamachar H, et al. Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues. Horm Mol Biol Clin Investig. 2012;9:173\u20138.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"920_CR58","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2217\/bmm-2018-0086","volume":"13","author":"Y Wei","year":"2019","unstructured":"Wei Y, Liu H, Wang C, et al. Clinicopathological and prognostic significance of octamer-binding transcription factor 4 in patients with gastric cancer: a systematic review and meta-analysis. Biomark Med. 2019;13:219\u201334.","journal-title":"Biomark Med"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00920-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00920-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00920-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:13:35Z","timestamp":1787123615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00920-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["920"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00920-2","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiments in this study were carried out by the \u201cGuiding Principles in the Care and Use of Animals\u201d (China) and approved by Laboratory animal management and ethics committee of Lishui University (No. 20250050).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"151"}}